Male Reproductive System Carcinoma — Trials

Male Reproductive System Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

1,218 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 452
Recruiting: 240
Ph III recruiting: 20
Growth YoY: +2.6%
Industry share: 25%
Top sponsor: Jonsson Comprehensive Cancer Center
Termination share: 34.9%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (190)

clinicaltrialsPublishedShowing 1–20 of 20 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT07667400	Docetaxel and SX-682 in Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma, Salivary Gland Carcinoma, and Advanced Prostate Cancer	not yet recruiting	Phase 1 / Phase 2	120	National Cancer Institute (NCI)NIH	1	Sep 30, 2026	clinicaltrials
NCT07850921	REGN21353 Alone or in Combination With Nezastomig for Metastatic Castration-Resistant Prostate Cancer in Adult Participants	not yet recruiting	Phase 1 / Phase 2	192	Regeneron PharmaceuticalsINDUSTRY	0	Sep 30, 2026